Percutaneous native renal biopsy adequacy: a successful interdepartmental quality improvement activity.

Abstract

Listen

Translate article

BackgroundAn adequate renal biopsy is essential for diagnosis and treatment of medical renal disease.ObjectiveWe evaluated two initiatives to improve adequacy of renal biopsy samples at our centre.DesignRetrospective determination of renal biopsy adequacy.SettingQueen Elizabeth II Health Sciences Centre.PatientsPatients undergoing medical renal biopsies.MeasurementsRenal biopsy adequacy.MethodsThe first initiative was to restrict the performance of biopsies to a smaller group of radiologists and to include a comment on biopsy adequacy in every pathology report. The second initiative was to introduce on-site adequacy assessment by a medical laboratory technologist. Native renal and allograft biopsy adequacies were calculated for three periods: 1) baseline, October 2005 to September 2006; 2) after implementation of the first initiative, January 2007 to September 2011; and 3) after implementation of the second initiative, October 2011 to September 2012. A subset of native renal biopsies was examined to determine if there was a relationship between adequacy and number of passes.ResultsThe percentages of adequate native renal biopsies during the first, second, and third periods were 31%, 72% and 90%, respectively. This represents a significant increase (40%, p < 0.0001) in adequacy following the first initiative, and another significant increase (18%, p = 0.0003) following the second initiative. The percentages of adequate renal allograft biopsies during the first, second, and third periods were 75%, 56% and 69%, respectively. These changes in adequacy were not statistically significant. In the subset of native renal biopsies examined, a biopsy comprising more than three cores was not associated with increase in adequacy.LimitationsThe most important limitation is the lack of generally accepted and applied adequacy criteria limiting generalizability of our findings.ConclusionsRestricting the performance of biopsies to subspecialist operators, including an adequacy statement in the renal biopsy report and on-site adequacy assessment were effective in significantly improving native renal biopsy adequacy. This improvement appeared unrelated to an increase in the number of passes taken with a biopsy needle. Neither initiative improved the low adequacy of allograft biopsies.